Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,571 | -2,210 | -1,347 | -597 | -1,863 |
| Depreciation Amortization | 4 | 3 | 2 | 1 | 4 |
| Accounts payable and accrued liabilities | -527 | -452 | -120 | -120 | -93 |
| Other Working Capital | -385 | -315 | -118 | -97 | 28 |
| Other Operating Activity | 1,187 | 947 | 450 | 285 | 771 |
| Operating Cash Flow | $-4,292 | $-2,027 | $-1,133 | $-528 | $-1,153 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -275 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -275 | -275 | -275 | -360 |
| Common Stock Issued | 3,111 | 2,548 | 2,548 | 2,548 | 30,167 |
| Financing Cash Flow | $2,835 | $2,273 | $2,273 | $2,273 | $29,807 |
| Beginning Cash Position | 28,660 | 28,660 | 28,660 | 28,660 | 7 |
| End Cash Position | 27,204 | 28,906 | 29,801 | 30,405 | 28,660 |
| Net Cash Flow | $-1,456 | $246 | $1,140 | $1,745 | $28,654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,292 | -2,027 | -1,133 | -528 | -1,153 |
| Free Cash Flow | -4,292 | -2,027 | -1,133 | -528 | -1,153 |